TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05502484

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrative Dialectical Behavioural Therapy (DBT)
Description: 8 weeks outpatient pre-treatment DBT followed by integrative, inpatient DBT of 40 weeks, using standard DBT, augmented with an experience-oriented, body-oriented skills training based on DBT-principles by trained DBT-therapists, and a follow-up phase of 12 weeks outpatient aftercare (maximal 8 sessions individual DBT and 4 booster sessions) and 12 weeks no DBT. The inpatient treatment takes place in a living environment that is based on the principles of DBT and takes into account several aspects of autism.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrative Dialectical Behavioural Therapy (DBT)
Description: 8 weeks outpatient pre-treatment DBT followed by integrative, inpatient DBT of 40 weeks, using standard DBT, augmented with an experience-oriented, body-oriented skills training based on DBT-principles by trained DBT-therapists, and a follow-up phase of 12 weeks outpatient aftercare (maximal 8 sessions individual DBT and 4 booster sessions) and 12 weeks no DBT. The inpatient treatment takes place in a living environment that is based on the principles of DBT and takes into account several aspects of autism.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrative Dialectical Behavioural Therapy (DBT)
Description: 8 weeks outpatient pre-treatment DBT followed by integrative, inpatient DBT of 40 weeks, using standard DBT, augmented with an experience-oriented, body-oriented skills training based on DBT-principles by trained DBT-therapists, and a follow-up phase of 12 weeks outpatient aftercare (maximal 8 sessions individual DBT and 4 booster sessions) and 12 weeks no DBT. The inpatient treatment takes place in a living environment that is based on the principles of DBT and takes into account several aspects of autism.
Study: NCT03186456

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic umbilical cord mesenchymal stem cells (SCLnow 19#)
Description: Allogeneic umbilical cord mesenchymal stem cells will transfusion into by forearm intravenous transplantation, 0.5 - 1 \*10\^6/kg. once a month, total 3 times.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspirin Tablet
Description: Drug: Aspirin Tablet, 100 mg/d

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Aspirin Tablet
Description: Drug: Aspirin Tablet, 100 mg/d
Study: NCT06547957

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EOS301984
Description: Multiple doses of EOS301984

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EOS301984
Description: Multiple doses of EOS301984
Study: NCT05611593

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOL100
Description: FOL100 lotion

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propecia 1Mg Tablet
Description: Oral Finasteride
Study: NCT05283070

Intervention type: OTHER
Intervention: Questionnaires, physical tests, and heart rate variability measures
Description: The 2MWT will be conducted in an unobstructed hallway with patients being asked to walk at moderate intensity (brisk walk) for the duration of the activity (2 minutes). The amount of distance in metres will be recorded.~The EMLi movement consists of pushing a 2kg weighted ball from the chest level forward, and then raising the ball overhead, before returning it to the starting position (Figure 1). The number of repetitions done at moderate intensity will be recorded after 60 seconds.~HRV and questionnaires previously listed

Intervention type: OTHER
Intervention: Questionnaires, physical tests, and heart rate variability measures
Description: The 2MWT will be conducted in an unobstructed hallway with patients being asked to walk at moderate intensity (brisk walk) for the duration of the activity (2 minutes). The amount of distance in metres will be recorded.~The EMLi movement consists of pushing a 2kg weighted ball from the chest level forward, and then raising the ball overhead, before returning it to the starting position (Figure 1). The number of repetitions done at moderate intensity will be recorded after 60 seconds.~HRV and questionnaires previously listed
Study: NCT04837352

Intervention type: OTHER
Intervention: Study of the role of sociocognitive factors
Description: Questionnaires
Study: NCT06547957

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-PD-1 monoclonal antibody
Description: Multiple doses of EOS301984 in combination with Anti-PD-1
Study: NCT04923594

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: mazindol extended release
Description: Dosed orally, once daily for up to 3 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dosed orally, once daily for up to 4 weeks.
Study: NCT05042726

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cTBS First
Description: Continuous θ-burst stimulation (cTBS) is characterized by plexus stimulation. The stimulation intensity was 80% resting motor threshold (RMT) at 50Hz of intra plexus pulse while the frequency of inter plexus pulse is 5Hz, the duration was 33.2s, and the number of stimulation pulses was 600. Two groups of stimulation were repeated in each cerebellar dentate nucleus with an interval of 5 min in each group.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pseudo-stimulation First
Description: The transcranial magnetic stimulator operating system has a built-in control group option, in which the stimulation parameters are set consistent with the research group, which can realize the operation of only sound without stimulation.
Study: NCT04492215

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interaction between patient and trained general practitioners in motivational interviewing
Description: Impact of the medical interview on the patient
Study: NCT05269121

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Phage Therapy
Description: Patient will undergo a DAIR procedure. After the DAIR, phage therapy will be administered in conjunction with antibiotic treatment.
Study: NCT04896970

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Concert
Description: A musical show in a closed hall, lasting for about 2 hours, in respects of safety measure (masks, hydroalcoholic gel, etc...) with approximately 200 participants.
Study: NCT05446831

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib
Description: Oral baricitinib was given at a dose of 4 mg daily. The decision to initiate rescue therapy was made after assessment of the extent of bleeding, patient preferences, lifestyle and activity, the complications of specific therapies, comorbidities that predisposed patients to bleeding and the tolerance of side effects. If a platelet count over 300,000/μL was observed for two consecutive tests at least 2 weeks apart, baricitinib treatment was interrupted.
Study: NCT05672667

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intravenous oxytocin
Description: Oxytocin given by intravenous route

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intranasal oxytocin
Description: Oxytocin given by intranasal administration
Study: NCT06458218

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Multi-component Interventions
Description: 1. Community-based spirometry pulmonary function tests and result interpretations and health education for COPD;~2. A digital health intervention program, EmoEase, for individuals with mental health issues among high-risk COPD population(very familiar with intelligent mobile phone);~3. NicQuit, digital health intervention to smokers;~4. Health education to smokers and individuals with mental health issues;~5. Encouragement to seek professional medication treatment in superior hospitals for spirometry-defined COPD patients;~6. To actively include individuals whose blood pressure and glucose are higher than the normal value into the National Essential Public Health Service in China;~7. A CBT-based health education to the BMI abnormal;~8. Pay-for-performance incentives to medical workers.
Study: NCT04894955

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MARIA
Description: After consent has been given, the participant's breast will be fitted by the operator using a clear plastic cup to ascertain their corresponding MARIA® cup insert size. Once this has been determined, participants will be required to lie prone with their breast pendent through an aperture in the MARIA® participant bed. The cup insert will contain a layer of coupling fluid. The hemispherical cup inserts and array are brought into contact with the breast. A scan sequence comprising of two complete scan rotations will then be performed, which takes around 5 minutes. The participant will then be assisted to adjust their positioning, and the scan sequence performed on the other breast.
Study: NCT04293016

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Support as usual
Description: This group receives current best practice which includes participation in ICU support groups and provision of community support resources

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Problem solving therapy
Description: This group will receive one on one therapy based on identifying stressors and solutions to those stressors

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ICU diary
Description: This group will be provided with a structured written diary that includes identification of stressors and development of solutions to those stressors
Study: NCT06519656

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mazdutide
Description: In the initial 4 weeks, the subjects are given Mazdutide 2mg once weekly. If well tolerated, the dosage is increased to 4mg once weekly for another 4 weeks. If still well tolerated, the dosage is further increased to 6mg once weekly and maintained for the ensuing 16 weeks.
Study: NCT05675449

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elranatamab
Description: BCMA-CD3 bispecific antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elranatamab
Description: BCMA-CD3 bispecific antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elranatamab
Description: BCMA-CD3 bispecific antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: proteasome inhibitor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maplirpacept
Description: CD47-SIRP alpha-directed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Maplirpacept
Description: CD47-SIRP alpha-directed
Study: NCT06164769

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: blocking both the abdominal trunk and superior mesenteric artery in the pancreatic enucleation
Description: In the pancreatic enucleation, Kocher Maneuver was routinely performed at first. Then free the left side of the abdominal trunk and superior mesenteric artery, loose tissues easy to free.After Kocher Maneuver and other surgical procedures, the abdominal trunk and superior mesenteric artery exposed. Before resection of pancreatic tumors, a vascular occlusion clamp clip was used to block the root of both the abdominal trunk and superior mesenteric artery to control the pancreatic blood flow.
Study: NCT05105763

Intervention type: OTHER
Group type: OTHER
Intervention: Sequential switched feedback training on the knee and the hip (Condition A)
Description: Condition A will include four 6-mins training blocks: 2-mins knee joint feedback-on, 2-mins hip joint feedback-on, and 2-mins feedback-off. Training with feedback on will occur as follows: The subject will walk on the treadmill and try to achieve the target hip and/or knee flexion pattern shown on the feedback interface. Training with feedback off will occur as follows: The subject will walk on the treadmill and try to maintain the pattern without any form of visual or verbal feedback.

Intervention type: OTHER
Group type: OTHER
Intervention: Sequential switched feedback training on the knee and the hip (Condition A)
Description: Condition A will include four 6-mins training blocks: 2-mins knee joint feedback-on, 2-mins hip joint feedback-on, and 2-mins feedback-off. Training with feedback on will occur as follows: The subject will walk on the treadmill and try to achieve the target hip and/or knee flexion pattern shown on the feedback interface. Training with feedback off will occur as follows: The subject will walk on the treadmill and try to maintain the pattern without any form of visual or verbal feedback.

Intervention type: OTHER
Group type: OTHER
Intervention: Feedback training on the knee alone (Condition B)
Description: Condition B will include four 6-mins training blocks: 4-mins knee joint feedback-on and 2-mins feedback-off. Training with feedback on will occur as follows: The subject will walk on the treadmill and try to achieve the target hip and/or knee flexion pattern shown on the feedback interface. Training with feedback off will occur as follows: The subject will walk on the treadmill and try to maintain the pattern without any form of visual or verbal feedback.

Intervention type: OTHER
Group type: OTHER
Intervention: Feedback training on the knee alone (Condition B)
Description: Condition B will include four 6-mins training blocks: 4-mins knee joint feedback-on and 2-mins feedback-off. Training with feedback on will occur as follows: The subject will walk on the treadmill and try to achieve the target hip and/or knee flexion pattern shown on the feedback interface. Training with feedback off will occur as follows: The subject will walk on the treadmill and try to maintain the pattern without any form of visual or verbal feedback.
Study: NCT04937504

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: STAIR-PC Group
Description: Skills Training in Affective and Interpersonal Regulation for Primary Care (STAIR-PC) is a face-to-face, individual, brief (5 session) therapy adapted from the STAIR program. STAIR-PC is an appropriate treatment for individuals who have experienced traumatic stressors, and addresses symptom targets by teaching skills to improve coping with emotions and strengthen interpersonal relationships.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WebSTAIR Group
Description: WebSTAIR is a web-based self-help program adapted from the STAIR program for individuals who have experienced traumatic stressors. WebSTAIR contains 10 self-guided interactive modules that teach skills to improve coping with emotions and strengthen interpersonal relationships.
Study: NCT06369714

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Concerta
Description: Methylphenidate Hydrochloride Extended-Release Tablets with the following specifications: 18mg dosage, oral administration, once a day for a duration of 8 weeks.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Concerta
Description: Methylphenidate Hydrochloride Extended-Release Tablets with the following specifications: 18mg dosage, oral administration, once a day for a duration of 8 weeks.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital therapeutics
Description: 30 sessions of digital therapeutics, each lasting 30 minutes, will be conducted with a frequency of once every 1-2 days over an 8-week period.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital therapeutics
Description: 30 sessions of digital therapeutics, each lasting 30 minutes, will be conducted with a frequency of once every 1-2 days over an 8-week period.
Study: NCT05951465

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine
Description: esketamine dose will be 0.3 mg/kg. Propofol dose for the first patient will be 2.5 mg/kg. Doses for the subsequent patients will increase or decrease by 0.8 mg/kg using the Dixon Up and Down method.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine
Description: esketamine dose will be 0.6 mg/kg. Propofol dose for the first patient will be 2.0 mg/kg. Doses for the subsequent patients will increase or decrease by 0.4 mg/kg using the Dixon Up and Down method.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: propofol

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: propofol
Study: NCT05228366

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heel warming with mild thermofor group
Description: Heel warming will be applied to the newborns in the ıntervention group 1 with a thermofor containing 34-37C warm water for 5 minutes before the heel blood collection procedure. During the procedure, the general condition of the newborn and the changes in his skin will be observed closely. Heel blood collection will be performed by following the standard procedure steps that are routinely applied in the service

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heel warming with hot thermofor group
Description: Heel warming will be applied to the newborns in the ıntervention group 2 with a thermofor containing 38-40C warm water for 5 minutes before the heel blood collection procedure. During the procedure, the general condition of the newborn and the changes in his skin will be observed closely. Heel blood collection will be performed by following the standard procedure steps that are routinely applied in the service

Intervention type: OTHER
Group type: OTHER
Intervention: Ineffective heel warming with thermofor group
Description: Ineffective heel warming will be applied to the newborns in the control group with a thermofor containing 28C warm water for 5 minutes before the heel blood collection procedure. During the procedure, the general condition of the newborn and the changes in his skin will be observed closely. Heel blood collection will be performed by following the standard procedure steps that are routinely applied in the service.
Study: NCT04019262

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy
Description: Radiation

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiation Therapy
Description: Radiation

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Temozolomide Oral Product
Description: Oral Temozolomide (150mg/m\^2 or 75 mg/m\^2)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Temozolomide Oral Product
Description: Oral Temozolomide (150mg/m\^2 or 75 mg/m\^2)
Study: NCT05293730

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eFRIEND
Description: eFRIEND is a 6-month CWH-led intervention. All CHW will be part of the research team to ensure successful recruitment and interaction with patients, and all CHW will be certified and have participated in the North Carolina Community Health Worker Standardized Core Competency Training.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Routine treatment in primary care
Study: NCT05682014

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Breastfeeding Program
Description: A web-based Mindful Breastfeeding Program, which is applied to pregnant women in groups of 5, consisting of 8 sessions, 2 sessions per week for 4 weeks.~Mindful breastfeeding program will consist of breastfeeding education, introduction to the concept of mindfulness, mindful breastfeeding, practical suggestions to pregnant women by the researcher, providing a discussion environment for them to share their experiences, and homework on the content of the program.~A web site with written material, video and audio recordings will be created and presented to the participants as a support element.~In order for them to use mindfulness practices in their daily lives, motivational WhatsApp short messages will be sent by the researcher daily during the training, weekly during the post-training period, and daily in the postpartum period.
Study: NCT06174350

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Description: Earthquake is a process that affects the lives of many people. It is very important to evaluate the psychological state of individuals after the earthquake and take appropriate action. When studies conducted after the earthquake were examined, no study was found that evaluated the effect of cognitive behavioral therapy on ruminative thoughts and cognitive distortions in individuals exposed to earthquakes. For this reason, this thesis was conducted to evaluate the effect of cognitive behavioral therapy on ruminative thoughts and cognitive distortions in individuals exposed to earthquakes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Intervention Description not
Study: NCT05372926

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high flow nasal canulae
Description: high flow nasal canulae is a oxygen therapy technic which allows the administration of warmed and humidified oxygen with a flow up to 50L/Min and a monitored FiO2. Physiological previous studies reported various effects of this technic especially on work of breathing. In our study the investigators aim to test this physiological property during exercise.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ventury mask
Description: Ventury mask is a oxygen therapy technic which allows the administration with a mask of oxygen with a flow up to 15L/Min and a monitored FiO2.
Study: NCT06440694

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg po
Description: Colchicine 0.5 mg po once daily for 180 days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo 0.5 mg po
Description: Placebo 0.5 mg po once daily for 180 days.
Study: NCT05810753

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SPOONful
Description: Participants will be asked to consume two ONS daily, in addition to their regular diet, for three weeks. Participants will be asked to consume one ONS with their breakfast, and one with lunch.
Study: NCT04769622

Intervention type: PROCEDURE
Intervention: Non-surgical periodontal treatment
Description: all included patients will be subjected to non-surgical periodontal therapy

Intervention type: OTHER
Intervention: Questionnaires
Description: All patients will be asked to complete a set of questionnaires regarding:~* adherence to Mediterranean Diet;~* sleep quality;~* physical activity;~* perceived stress.